Alvotech is trading 4.72% down at ISK 606.00, with the decline most likely occurring amid the October 22 global selloff over renewed concerns about AI spending and rising oil prices.
- Reuters reported broad stock-market losses on October 22.
- Alvotech filed a lawsuit challenging AbbVie’s Humira patent defenses on October 22; available reporting does not establish that the filing drove the share move.